2012
|
Sign up to set email alerts
Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS
Kathir Yoganathan
Search citation statements
Order By: Relevance
Paper Sections
Select...
8
4
0
0
Citation Types
1
9
0
0
Year Published
Range
2013
20132026
2026Publication Types
Select...
11
1
Relationship
0
12
Authors
Journals
Cited by 12 publications
(10 citation statements)
References 24 publications
1
9
0
0
Order By: Relevance
Smart CitationsHow the paper below cites the one you are viewing
“…Two of our three patients (66%) are alive at one-year follow-up, which is in line with recently reported survival rates of approximately 50-70% on effective ART [12,13]. This modest improvement in mortality relative to pre-HAART times reflects what Yoganathan et al described-namely, better prognoses are seen in those who demonstrate immune recovery (i.e., rising CD4 counts and clearance of JCV from CSF) on therapy [20]. Even so, PML remains a life-threatening illness.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Two of our three patients (66%) are alive at one-year follow-up, which is in line with recently reported survival rates of approximately 50-70% on effective ART [12,13]. This modest improvement in mortality relative to pre-HAART times reflects what Yoganathan et al described-namely, better prognoses are seen in those who demonstrate immune recovery (i.e., rising CD4 counts and clearance of JCV from CSF) on therapy [20]. Even so, PML remains a life-threatening illness.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…A very different disease course was described by Yoganathan et al ( 2012 ). This author presented a case of a 43-year-old male with AIDS who recovered from PML to a great extent.…”
Section: Discussion
mentioning
confidence: 74%
“…According to Engsig et al, introducing ARV increased median survival time significantly: from 0.4 years to 1.8 years (Engsig et al 2009 ). Furthermore, some patients live much longer, Lima et al ( 2010 ) described 24 patients (23 of them being HIV-positive, all receiving ARV) whose survival time exceeded years, and Yoganathan et al ( 2012 ), a patient who was still alive 12 years after the diagnosis. All this data stands in contrast to our patients’ outcomes.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…It may be called a probable PML because there were clinical and imaging features of the disease but neither CSF examination as to the presence of JCV DNA nor histopathology with demonstration of JCV DNA/protein were done [15]. In HIV infection antiretroviral therapy is the principal approach in case of PML and neurological and radiological improvement in our patient after 10 months of antiretroviral treatment duration could confirm the suspicion of the disease [16].…”
Section: Discussion
mentioning
confidence: 74%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Two of our three patients (66%) are alive at one-year follow-up, which is in line with recently reported survival rates of approximately 50-70% on effective ART [12,13]. This modest improvement in mortality relative to pre-HAART times reflects what Yoganathan et al described-namely, better prognoses are seen in those who demonstrate immune recovery (i.e., rising CD4 counts and clearance of JCV from CSF) on therapy [20]. Even so, PML remains a life-threatening illness.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…A very different disease course was described by Yoganathan et al ( 2012 ). This author presented a case of a 43-year-old male with AIDS who recovered from PML to a great extent.…”
Section: Discussion
mentioning
confidence: 74%
“…According to Engsig et al, introducing ARV increased median survival time significantly: from 0.4 years to 1.8 years (Engsig et al 2009 ). Furthermore, some patients live much longer, Lima et al ( 2010 ) described 24 patients (23 of them being HIV-positive, all receiving ARV) whose survival time exceeded years, and Yoganathan et al ( 2012 ), a patient who was still alive 12 years after the diagnosis. All this data stands in contrast to our patients’ outcomes.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…It may be called a probable PML because there were clinical and imaging features of the disease but neither CSF examination as to the presence of JCV DNA nor histopathology with demonstration of JCV DNA/protein were done [15]. In HIV infection antiretroviral therapy is the principal approach in case of PML and neurological and radiological improvement in our patient after 10 months of antiretroviral treatment duration could confirm the suspicion of the disease [16].…”
Section: Discussion
mentioning
confidence: 74%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Two of our three patients (66%) are alive at one-year follow-up, which is in line with recently reported survival rates of approximately 50-70% on effective ART [12,13]. This modest improvement in mortality relative to pre-HAART times reflects what Yoganathan et al described-namely, better prognoses are seen in those who demonstrate immune recovery (i.e., rising CD4 counts and clearance of JCV from CSF) on therapy [20]. Even so, PML remains a life-threatening illness.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…A very different disease course was described by Yoganathan et al ( 2012 ). This author presented a case of a 43-year-old male with AIDS who recovered from PML to a great extent.…”
Section: Discussion
mentioning
confidence: 74%
“…According to Engsig et al, introducing ARV increased median survival time significantly: from 0.4 years to 1.8 years (Engsig et al 2009 ). Furthermore, some patients live much longer, Lima et al ( 2010 ) described 24 patients (23 of them being HIV-positive, all receiving ARV) whose survival time exceeded years, and Yoganathan et al ( 2012 ), a patient who was still alive 12 years after the diagnosis. All this data stands in contrast to our patients’ outcomes.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…It may be called a probable PML because there were clinical and imaging features of the disease but neither CSF examination as to the presence of JCV DNA nor histopathology with demonstration of JCV DNA/protein were done [15]. In HIV infection antiretroviral therapy is the principal approach in case of PML and neurological and radiological improvement in our patient after 10 months of antiretroviral treatment duration could confirm the suspicion of the disease [16].…”
Section: Discussion
mentioning
confidence: 74%
Abstract